RT Journal Article
SR Electronic
T1 Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.28.21258847
DO 10.1101/2021.06.28.21258847
A1 Saeed, Balsam Qubais
A1 Al-Shahrabi, Rula
A1 Alhaj, Shaikha Salah
A1 Alkokhardi, Zainab Mansour
A1 Adrees, Ahmed Omar
YR 2021
UL http://medrxiv.org/content/early/2021/07/01/2021.06.28.21258847.abstract
AB Background Vaccines are one of the best interventions developed for eradicating COVID-19, the rapid creation of vaccinations was increased the risk of vaccine safety problems. The aim of this study to provide evidence on Sinopharm COVID-19 vaccine side effects which is approved by the United Arab Emirates (UAE).Methods A cross-sectional survey study was conducted between January and April 2021 to collect data on the effects of COVID-19 vaccine among individuals in the UAE. Demographic data, chronic conditions, side effects of the 1st and 2nd dose toward the vaccination, and the response of unwilling taking COVID-19 vaccine were reported.Results The most common side effects of post 1st dose vaccination among participants (≤49 years old vs >49 years) were normal injection site pain 42.2%, fatigue 12.2%, and headache 9.6%, while pain at the vaccination site 32.6%, fatigue16.3%, lethargy13.7%, headache10%, and tenderness 10% were the most side effects of the post 2nd dose of vaccination in both groups. All the side effects in both doses were more prevalent among the participants ≤ 49-year-old group.Among two groups (females vs males), the study revealed the increase in the number of females that suffered from the vaccine side effects compared with males in both doses. The most prevalence adverse reactions of first dose in (female’s vs males) were fatigue (15.8% vs 3.75%), lethargy (12.6% vs 1.25%), headache (10.5% vs 7.5%), while in 2nd dose were fatigue (20% vs 7.5%), sever injection site pain (10.5% vs 2.5%). The most common reason of not willing to take the COVID-19 vaccine among the participants were the vaccines are not effective, and the participants were not authorized to take vaccine.Conclusion The 1st and 2nd dose post-vaccination side effects were mild, predictable, and there were no hospitalization cases, this data will help to reduce the vaccine hesitancy.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Research Ethics Committee of university of Sharjah in the on: 22/3/2021, with the reference No: REC-21-02-09-07.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data available